Cytosolic p53 inhibits Parkin-mediated mitophagy and promotes mitochondrial dysfunction in the mouse heart
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Cumulative evidence indicates that mitochondrial dysfunction has a role in heart failure progression, but whether mitochondrial quality control mechanisms are involved in the development of cardiac dysfunction remains unclear. Here we show that cytosolic p53 impairs autophagic degradation of damaged mitochondria and facilitates mitochondrial dysfunction and heart failure in mice. Prevalence and induction of mitochondrial autophagy is attenuated by senescence or doxorubicin treatment in vitro and in vivo. We show that cytosolic p53 binds to Parkin and disturbs its translocation to damaged mitochondria and their subsequent clearance by mitophagy. p53-deficient mice show less decline of mitochondrial integrity and cardiac functional reserve with increasing age or after treatment with doxorubicin. Furthermore, overexpression of Parkin ameliorates the functional decline in aged hearts, and is accompanied by decreased senescence-associated β-galactosidase activity and proinflammatory phenotypes. Thus, p53-mediated inhibition of mitophagy modulates cardiac dysfunction, raising the possibility that therapeutic activation of mitophagy by inhibiting cytosolic p53 may ameliorate heart failure and symptoms of cardiac ageing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Defective mitophagy has also been linked with premature aging and many age-associated disorders, such as Alzheimer’s and Parkinson’s diseases (25–28).”
From Impaired mitophagy leads to cigarette smoke stress‐induced cellular senescence: implications for chronic obstructive pulmonary disease (2015) · cites this paper as [27]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A recent study has shown that increased p53 cytosolic localization prevents Parkin translocation to mitochondria during organismal aging (27).”
From Impaired mitophagy leads to cigarette smoke stress‐induced cellular senescence: implications for chronic obstructive pulmonary disease (2015) · cites this paper as [27]
Experimental — accuracy not yet measuredIn the citing paper
“| Cardiomyopathies | Whole‐body deletion of Tp53 | Decelerated cardiac aging, linked to improved mitophagic responses after stabilization of PRKN | Hoshino et al (2013) |”
From Autophagy in major human diseases (2021) · cites this paper as Hoshino et al (2013)
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Parkin is recruited selectively to impaired mitochondria and promotes their autophagy
Narendra, D., Tanaka, A., Suen, D.-F., & Youle, R. J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200809125 · Cited by 4,026
Youle, R. J., & Narendra, D. P. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3028 · Cited by 3,273
Fission and selective fusion govern mitochondrial segregation and elimination by autophagy
Twig, G., Elorza, A., Molina, A. J. A., Mohamed, H., Wikstrom, J. D., Walzer, G., Stiles, L., Haigh, S. E., Katz, S., Las, G., et al. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601963 · Cited by 3,082
PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1
Geisler, S., Holmström, K. M., Skujat, D., Fiesel, F. C., Rothfuss, O. C., Kahle, P. J., & Springer, W. (2010) · Nature Cell Biology · doi:10.1038/ncb2012 · Cited by 2,835
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803
Premature ageing in mice expressing defective mitochondrial DNA polymerase
Trifunovic, A., Wredenberg, A., Falkenberg, M., Spelbrink, J. N., Rovio, A. T., Bruder, C. E., Bohlooly-Y, M., Gidlöf, S., Oldfors, A., Wibom, R., et al. (2004) · Nature · doi:10.1038/nature02517 · Cited by 2,734
The Failing Heart — An Engine Out of Fuel
Neubauer, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmra063052 · Cited by 2,417
Vousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,272
Cited by
Items 101–200 of 533
Sun, T., Ding, W., Xu, T., Ao, X., Yu, T., Li, M., Liu, Y., Zhang, X., Hou, L., & Wang, J. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2019.7734 · Cited by 117
“Parkin reduction participates in cardiac pathological process, but the underlying mechanism is not known (20, 23, 24).”
InfluentialMitochondrial dysfunction and its association with age-related disorders
Somasundaram, I., Jain, S. M., Blot‐Chabaud, M., Pathak, S., Banerjee, A., Rawat, S. J., Sharma, N. R., & Duttaroy, A. K. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1384966 · Cited by 139
Monoamine Oxidases, Oxidative Stress, and Altered Mitochondrial Dynamics in Cardiac Ageing
Maggiorani, D., Manzella, N., Edmondson, D. E., Mattevi, A., Parini, A., Binda, C., & Mialet‐Perez, J. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/3017947 · Cited by 124
“Interestingly, parkin deficiency in mice led to the progressive accumulation of dysfunctional mitochondria whereas parkin overexpression maintained mitochondrial integrity in the ageing heart [13].”
BackgroundThis old heart: Cardiac aging and autophagy
Linton, P.-J., Gurney, M., Sengstock, D., Mentzer, R. M., & Gottlieb, R. A. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.12.017 · Cited by 114
“Overexpression of Parkin, a ubiquitin ligase important for mitochondrial turnover, ameliorated the age-related decline in cardiac function [78], whereas Parkin deficiency results in accumulation of abnormal mitochondria, particularly after injury [79].”
BackgroundMending a broken heart: the role of mitophagy in cardioprotection
Moyzis, A. G., Sadoshima, J., & Gustafsson, Å. B. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00708.2014 · Cited by 112
Nuclear p53-mediated repression of autophagy involves PINK1 transcriptional down-regulation
Goiran, T., Duplan, E., Rouland, L., el Manaa, W., Lauritzen, I., Dunys, J., You, H., Checler, F., & Alves da Costa, C. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0016-0 · Cited by 110
“Thus, cytoplasmic p53 affects parkin translocation to the mitochondria, enabling its interplay with PINK1 and thereby, elimination of malfunctioning mitochondria by mitophagy [30].”
BackgroundParkin is required for exercise-induced mitophagy in muscle: Impact of aging
Chen, C. C. W., Erlich, A. T., Crilly, M. J., & Hood, D. A. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00391.2017 · Cited by 108
Marques‐Aleixo, I., Alves, E. S., Mariani, D., Rizo‐Roca, D., Padrão, A. I., Rocha‐Rodrigues, S., Viscor, G., Torrella, J. R., Ferreira, R. M., Oliveira, P. J., et al. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.10.008 · Cited by 122
Ji, W., Wei, S., Hao, P., Xing, J., Yuan, Q., Wang, J., Xu, F., & Chen, Y. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00101 · Cited by 106
Mitophagy in Cardiovascular Diseases
Morciano, G., Patergnani, S., Bonora, M., Pedriali, G., Tarocco, A., Bouhamida, E., Marchi, S., Ancora, G., Anania, G., Wieckowski, M. R., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030892 · Cited by 113
“This process impairs the reuse of dysfunctional mitochondria and subsequently induces the development of cardiac dysfunction [67] (Table 1).”
BackgroundManzella, N., Santin, Y., Maggiorani, D., Martini, H., Douin‐Echinard, V., Passos, J. F., Lezoualc'h, F., Binda, C., Parini, A., & Mialet‐Perez, J. (2018) · Aging Cell · doi:10.1111/acel.12811 · Cited by 106
Kubli, D. A., Cortez, M. Q., Moyzis, A. G., Najor, R. H., Lee, Y., & Gustafsson, Å. B. (2015) · PLOS ONE · doi:10.1371/journal.pone.0130707 · Cited by 102
“Studies have shown that both BNIP3/NIX- and PINK1/Parkin-mediated mitophagy are involved in the normal turnover of mitochondria in the myocardium [16, 39, 40].”
BackgroundMethodWang, P., Wang, L., Lü, J., Hu, Y., Wang, Q., Li, Z., Cai, S., Liang, L., Guo, K., Xie, J., et al. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.06.005 · Cited by 104
The role of mitochondrial cardiolipin in heart function and its implication in cardiac disease
Dudek, J., Hartmann, M., & Rehling, P. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.08.025 · Cited by 113
The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer’s disease
Jazvinšćak Jembrek, M., Slade, N., Hof, P. R., & Šimić, G. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.05.001 · Cited by 100
“If deficiency in DNA repair is present and DNA damage persists, the aggregates are much more likely to accumulate that in turn results in increased ROS production and further DNA damage, stimulating further activation of p53 and GSK-3β and even more aggregation (Proctor and Gray, 2010).”
InfluentialJembrek, M. J., Oršolić, N., Mandić, L., Sadžak, A., & Šegota, S. (2021) · Antioxidants · doi:10.3390/antiox10101628 · Cited by 124
Understanding Anthracycline Cardiotoxicity From Mitochondrial Aspect
Huang, J., Wu, R., Chen, L., Yang, Z., Yan, D., & Li, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.811406 · Cited by 118
“Anthracyclines activate p53, subsequently promoting its direct binding and sequestering Parkin in the cytosol, thus hindering the recruitment of Parkin to mitochondria and preventing mitophagy initiation (Hoshino et al., 2013).”
BackgroundInfluentialMetformin restores parkin-mediated mitophagy, suppressed by cytosolic p53
Song, Y., Lee, W., Lee, Y.-H., Kang, E., Cha, B.-S., & Lee, B.-W. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010122 · Cited by 98
“In addition, recent studies have reported that cytosolic p53 interferes with mitochondrial integrity and mitophagy [6,7] by inhibiting the removal of damaged mitochondria through an i hibitory interaction with Parkin, thereby inducing itochon rial dysfunction [8,9].”
BackgroundRen, X., Chen, L., Xie, J., Zhang, Z., Dong, G., Liang, J., Liu, L., Zhou, H., & Luo, P. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/4175353 · Cited by 103
“The overexpression of parkin ameliorated cardiac aging and maintained mitochondrial integrity [52].”
BackgroundLi, Y., Ma, Y., Song, L., Yu, L., Zhang, L., Zhang, Y., Xing, Y., Yin, Y., & Ma, H. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3555 · Cited by 97
“Parkin can be bound by activated p53 (acetylated), which then blocks its translocation (35).”
Miyamoto, S. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0286-9 · Cited by 105
Scheffer, D. D. L., Garcia, A. A., Lee, L., Mochly‐Rosen, D., & Ferreira, J. C. B. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0145 · Cited by 103
“Parkin-deficient mice accumulate dysfunctional mitochondria and have elevated levels of oxidative stress, along with pathological cardiac remodeling and reduced left ventricle fractional shortening (74, 86).”
Whelan, K. A., Chandramouleeswaran, P. M., Tanaka, K., Natsuizaka, M., Guha, M., Srinivasan, S., Darling, D. S., Kita, Y., Natsugoe, S., Winkler, J. D., et al. (2017) · Oncogene · doi:10.1038/onc.2017.102 · Cited by 97
“17 As such, it is tempting to speculate that differential cell fates induced by TGF-β in non-transformed (wild type p53) and transformed (overexpression of mutant p53, EGFR and Cyclin D1) esophageal keratinocytes may be related to the ability of these cells to modulate mitophagy via p53.”
Lee, P., Vousden, K. H., & Cheung, E. C. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-1 · Cited by 107
“While these results suggest that p53 helps to maintain mitochondrial quality, other studies have also demonstrated a role for p53 in the inhibition of mitophagy, an effect that would lead to increased mitochondrial dysfunction [50-52].”
BackgroundMitochondrial redox system, dynamics, and dysfunction in lung inflammaging and COPD
Lerner, C. A., Sundar, I. K., & Rahman, I. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.07.026 · Cited by 108
“Hoshino et al. showed p53 binds to Parkin and restricts its translocation to mitochondria which compromises autophagy and promotes mitochondrial dysfunction (Hoshino et al., 2013).”
BackgroundParkin-dependent mitophagy in the heart
Dorn, G. W. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.11.023 · Cited by 96
“cardiomyocyte-specific Parkin deficiency [36, 37].”
Bloemberg, D., & Quadrilatero, J. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00261.2018 · Cited by 105
Macroautophagy and aging: The impact of cellular recycling on health and longevity
Nieto-Torres, J. L., & Hansen, M. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.101020 · Cited by 99
PINK1/Parkin-mediated mitophagy in cardiovascular disease: From pathogenesis to novel therapy
Wu, Y., Jiang, T., Hua, J., Xiong, Z., Dai, K., Chen, H., Li, L., Peng, J., Peng, X., Zheng, Z., et al. (2022) · International Journal of Cardiology · doi:10.1016/j.ijcard.2022.05.025 · Cited by 98
Functions of Autophagy in Pathological Cardiac Hypertrophy
Li, Z., Wang, J., & Yang, X. Y. (2015) · International Journal of Biological Sciences · doi:10.7150/ijbs.11883 · Cited by 97
“Parkin-overexpression or p53-deficiency ameliorates the functional decline in aging hearts accompanied by decreased senescence-associated β-galactosidase activity [61, 62].”
BackgroundMechanisms, pathophysiological roles and methods for analyzing mitophagy – recent insights
Williams, J. A. R., & Ding, W. (2018) · Biological Chemistry · doi:10.1515/hsz-2017-0228 · Cited by 94
“leading to mitochondrial dysfunction and heart failure in mice after doxorubicin treatment (Hoshino et al., 2013).”
BackgroundMitochondrial quality control in cardiomyocytes: safeguarding the heart against disease and ageing
Ravindran, R., & Gustafsson, Å. B. (2025) · Nature Reviews Cardiology · doi:10.1038/s41569-025-01142-1 · Cited by 98
“However, in mice, increasing Parkin-mediated mitophagy in the heart improves mitochondrial health and delays cardiac ageing 64 .”
Hammerling, B. C., & Gustafsson, Å. B. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.07.013 · Cited by 91
“Cardiac specific Parkin transgenic mice are resistant to aging and aged mice exhibit fewer dysfunctional mitochondria compared to age-matched wild type controls [99].”
BackgroundMultitasking guardian of mitochondrial quality: Parkin function and Parkinson’s disease
Kamienieva, I., Duszyński, J., & Szczepanowska, J. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-020-00229-8 · Cited by 87
Yuan, Y., Zhao, J., Gong, Y., Wang, D., Wang, X., Yun, F., Liu, Z., Zhang, S., Li, W., Zhao, X., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0860-y · Cited by 93
Liang, W., Moyzis, A. G., Lampert, M. A., Diao, R. Y., Najor, R. H., & Gustafsson, Å. B. (2020) · Aging Cell · doi:10.1111/acel.13187 · Cited by 80
“The importance of Parkin in clearing damaged mitochondria in myocytes during acute stress is well established (Hoshino et al., 2013; Kubli, Quinsay, & Gustafsson, 2013).”
BackgroundEndoplasmic reticulum stress-mediated mitochondrial dysfunction in aged hearts
Chen, Q., Samidurai, A., Thompson, J., Hu, Y., Das, A., Willard, B. B., & Lesnefsky, E. J. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165899 · Cited by 83
Lérida‐Viso, A., Estepa‐Fernández, A., Morellá‐Aucejo, Á., Lozano‐Torres, B., Alfonso, M., Blandez, J. F., Bisbal, V., Sepúlveda, P., García‐Fernández, A., Orzáez, M., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106356 · Cited by 89
Models of Heart Failure Based on the Cardiotoxicity of Anticancer Drugs
Mercurio, V., Pirozzi, F., Lazzarini, E., Marone, G., Rizzo, P., Agnetti, G., Tocchetti, C. G., Ghigo, A., & Ameri, P. (2016) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2016.04.008 · Cited by 88
Ye, C., Chen, Y., Bian, S.-J., Li, X., Li, Y., Wang, K., Zhu, Y., Wang, L., Wang, Y., Wang, Y., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02705-z · Cited by 81
“Conversely, others observed inhibition of autophagy [34] or Parkin-mediated mitophagy [35] in DOX-treated cardiac cells.”
BackgroundA time to reap, a time to sow: Mitophagy and biogenesis in cardiac pathophysiology
Andres, A. M., Stotland, A., Queliconi, B. B., & Gottlieb, R. A. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.10.003 · Cited by 78
“Excessive autophagy has been implicated in doxorubicin-mediated cardiac injury [162,163], although other studies have reported a beneficial role for autophagy [164–167].”
BackgroundEmerging Role of the Nucleolar Stress Response in Autophagy
Pfister, A. S. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00156 · Cited by 80
Autophagy and mitophagy in the myocardium: therapeutic potential and concerns
Jimenez, R. E., Kubli, D. A., & Gustafsson, Å. B. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12477 · Cited by 76
“This study found that cytosolic p53 binds to Parkin and prevents its translocation to damaged mitochondria and their subsequent clearance by mitophagy in doxorubicin-treated hearts (Hoshino et al., 2013).”
BackgroundAAV-mediated in vivo functional selection of tissue-protective factors against ischaemia
Ruozi, G., Bortolotti, F., Falcione, A., Dal Ferro, M., Ukovich, L., Macedo, A., Zentilin, L., Filigheddu, N., Cappellari, G. G., Baldini, G., et al. (2015) · Nature Communications · doi:10.1038/ncomms8388 · Cited by 76
“…induction of autophagy protects against ischemia/reperfusion injury 18, 46 , limits cell death and tissue damage following acute MI 47 , represents a pro-survival mechanism in chronically ischemic myocardium 48 and constitutes a quality control mechanism to remove damaged mitochondria 49 .”
Oral, Ö., Akkoç, Y., Bayraktar, O., & Gözüaçık, D. (2016) · PubMed · doi:10.14670/hh-11-714 · Cited by 90
“Autophagy was shown to protect cardiomyocytes from the toxicity of abnormal protein aggregation in mouse models of cardiomyopathy (Hoshino et al., 2013).”
BackgroundMitochondrial autophagy in cardiomyopathy
Tong, M., & Sadoshima, J. (2016) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2016.02.006 · Cited by 78
Yarana, C., & Clair, D. K. S. (2017) · Antioxidants · doi:10.3390/antiox6040075 · Cited by 83
“Hoshino and colleagues reported that Dox-induced p53 activation leads to the interaction and sequestration of PINK-1 by p53 [33].”
Role of Mitophagy in Cardiovascular Disease
Yang, Y., Li, T., Li, Z., Liu, N., Yan, Y., & Liu, B. (2020) · Aging and Disease · doi:10.14336/ad.2019.0518 · Cited by 74
“For example, mitophagy is disrupted in the heart of aged individuals and in senescent cells and DOXtreated hearts and cells [19, 86].”
BackgroundVascular autophagy in health and disease
Hughes, W. E., Beyer, A., & Gutterman, D. D. (2020) · Basic Research in Cardiology · doi:10.1007/s00395-020-0802-6 · Cited by 76
Mutant p53 as a Regulator and Target of Autophagy
Shi, Y., Norberg, E., & Vakifahmetoglu-Norberg, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.607149 · Cited by 86
Mitochondrial quality control in the diabetic heart
Liang, Q., & Kobayashi, S. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.12.025 · Cited by 77
Regulation of cell death in the cardiovascular system
(2020) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2019.11.005 · Cited by 69
Parkinson's disease proteins: Novel mitochondrial targets for cardioprotection
Mukherjee, U., Ong, S., Ong, S., & Hausenloy, D. J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.10.005 · Cited by 76
Luan, Y., Luan, Y., Feng, Q., Chen, X., Ren, K., & Yang, Y. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/3259963 · Cited by 72
“, mitophagy impairment promotes HF progression in mice through the recruitment of p53 to Parkin and p53 sequestration [90].”
BackgroundTranscriptional regulation of autophagy and its implications in human disease
Lei, Y., & Klionsky, D. J. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01162-9 · Cited by 76
“Besides the inhibition by the cytosolic TP53 via binding to PRKN [55], nuclear TP53 also suppresses mitophagy through transcriptional repression of PINK1, another important protein in mitophagy [56].”
BackgroundDudek, J., & Maack, C. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx014 · Cited by 79
Role of Senescence and Aging in SARS-CoV-2 Infection and COVID-19 Disease
Lynch, S. M., Guo, G., Gibson, D. S., Bjourson, A. J., & Singh, T. (2021) · Cells · doi:10.3390/cells10123367 · Cited by 77
“Senescence can also be triggered in terminally differentiated cells such as neurons [24–26], and cardiomyocytes [27,28].”
BackgroundMacroautophagy and Chaperone‐Mediated Autophagy in Heart Failure: The Known and the Unknown
Ghosh, R., & Pattison, J. S. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/8602041 · Cited by 75
“The cardioprotective nature of mitophagy was further confirmed in various genetically modified mouse models [213, 216].”
BackgroundMitochondrial dysfunction in heart failure and its therapeutic implications
Liu, M., Lv, J., Pan, Z., Wang, D., Zhao, L., & Guo, X. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.945142 · Cited by 83
“Mitophagy is impaired in aged and doxorubicin-treated hearts, and inhibition of Parkin-mediated mitophagy subsequently promotes cardiac dysfunction and overexpression of Parkin attenuates the functional decline in mouse hearts (105).”
BackgroundHoshino, A., Okawa, Y., Ariyoshi, M., Kaimoto, S., Uchihashi, M., Fukai, K., Iwai-Kanai, E., & Matoba, S. (2014) · Circulation: Heart Failure · doi:10.1161/circheartfailure.113.001062 · Cited by 67
“We previously reported that the autophagic degradation of mitochondria was attenuated by an inhibitory protein–protein interaction between Parkin and cytosolic p53, which contributed to declines in mitochondrial integrity and cardiac contractility in a mouse model of heart failure induced by doxorubicin treatment or c…”
BackgroundSelf-citationEven, B., Fayad‐Kobeissi, S., Gagliolo, J., Motterlini, R., Boczkowski, J., Foresti, R., & Dagouassat, M. (2018) · Aging Cell · doi:10.1111/acel.12837 · Cited by 70
“Indeed, cytoplasmic p53, which accumulates in senescence, interacts with Parkin and prevents its translocation to dysfunctional mitochondria, thus suppressing mitophagy (Ahmad et al., 2015; Hoshino et al., 2013).”
BackgroundBonora, M., Morganti, C., van Gastel, N., Ito, K., Calura, E., Zanolla, I., Ferroni, L., Zhang, Y., Jung, Y., Sales, G., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.02.004 · Cited by 74
Cardiac senescence is alleviated by the natural flavone acacetin via enhancing mitophagy
Hong, Y., Wu, W., Song, F., Wu, C., Li, G., & Wang, Y. (2021) · Aging · doi:10.18632/aging.203163 · Cited by 68
“Increasing evidence shows that Parkin deficiency accelerates aging phenotype and cause accumulation of aberrant mitochondria in aging heart [11–13], while cardiac specific overexpression of Parkin can ameliorate cardiac aging by enhancing mitochondrial turnover [13].”
BackgroundUnbreak My Heart: Targeting Mitochondrial Autophagy in Diabetic Cardiomyopathy
Kubli, D. A., & Gustafsson, Å. B. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2015.6322 · Cited by 64
“As a result, the removal of damaged mitochondria is abrogated and dysfunctional mitochondria accumulate, leading to cardiac functional decline (64).”
BackgroundRedox biology and the interface between bioenergetics, autophagy and circadian control of metabolism
Wende, A. R., Young, M. E., Chatham, J. C., Zhang, J., Rajasekaran, N. S., & Darley-Usmar, V. M. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.05.022 · Cited by 69
Comprehensive autophagy evaluation in cardiac disease models
Kaludercic, N., Maiuri, M. C., Kaushik, S., Fernández, Á. F., de Bruijn, J., Castoldi, F., Chen, Y., Ito, J., Mukai, R., Murakawa, T., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvz233 · Cited by 64
“Consistent with this idea, overexpression of Parkin has been shown to reduce ageassociated cardiac abnormalities.(25) 2.”
BackgroundLacombe, A., & Scorrano, L. (2024) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2024.02.001 · Cited by 73
Exercise Alleviates Cardiovascular Diseases by Improving Mitochondrial Homeostasis
Zhang, H., Zhang, Y., Zhang, J., & Jia, D. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.036555 · Cited by 77
Rizzo, F., Ronchi, D., Salani, S., Nizzardo, M., Fortunato, F., Bordoni, A., Stuppia, G., Bo, R. D., Piga, D., Fato, R., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw258 · Cited by 72
New methods for monitoring mitochondrial biogenesis and mitophagy in vitro and in vivo
Williams, J. A. R., Zhao, K., Jin, S., & Ding, W. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370216688802 · Cited by 72
Defective insulin signaling and mitochondrial dynamics in diabetic cardiomyopathy
Westermeier, F., Navarro-Marquez, M., López-Crisosto, C., Bravo-Sagua, R., Quiroga, C., Bustamante, M., Verdejo, H. E., Zalaquett, R., Ibacache, M., Parra, V., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.02.005 · Cited by 61
Exercise and Doxorubicin Treatment Modulate Cardiac Mitochondrial Quality Control Signaling
Marques‐Aleixo, I., Alves, E. S., Torrella, J. R., Oliveira, P. J., Magalhães, J., & Ascensão, A. A. M. R. (2017) · Cardiovascular Toxicology · doi:10.1007/s12012-017-9412-4 · Cited by 70
Effects of aging and exercise training on mitochondrial function and apoptosis in the rat heart
No, M., Heo, J., Yoo, S.-Z., Kim, C., Park, D., Kang, J., Seo, D. Y., Han, J., & Kwak, H. (2020) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-020-02357-6 · Cited by 66
Cardio-Oncology: A Myriad of Relationships Between Cardiovascular Disease and Cancer
Wang, Y., Wang, Y., Han, X., Sun, J. H., Li, C., Adhikari, B. K., Zhang, J., Miao, X., & Chen, Z. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.727487 · Cited by 71
“Cancer Treatment Is Prone to Cardiovascular Disease Cardiotoxicity due to antineoplastic therapy is induced by multiple factors, mainly including oxidative stress (99) [OS; including mitochondrial functional impairment (100), myocardial apoptosis (101, 102)], microtubule dysfunction (103, 104), and disruption of myoca…”
BackgroundLeucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21WAF1/CIP1 expression
Ho, D. H., Kim, H. J., Kim, J., Sim, H., Ahn, H. M., Kim, J., Seo, H., Chung, K. C., Park, B.-J., Son, I., et al. (2015) · Molecular Brain · doi:10.1186/s13041-015-0145-7 · Cited by 65
“In addition, cytosolic p53 inhibits mitophagy mediated by Parkin in mouse hearts [69].”
BackgroundResultThe Aging Heart: Mitophagy at the Center of Rejuvenation
Liang, W., & Gustafsson, Å. B. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00018 · Cited by 69
“Parkin-deficient mice have an accelerated aging phenotype and accumulate aberrant mitochondria in aging heart (58, 65) while cardiac specific overexpression of Parkin can delay cardiac aging by enhancing mitochondrial turnover (65).”
BackgroundAn update of the molecular mechanisms underlying anthracycline induced cardiotoxicity
Xie, S., Sun, Y., Zhao, X., Xiao, Y., Zhou, F., Lin, L., Wang, W., Lin, B., Wang, Z., Fang, Z., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1406247 · Cited by 75
TP53 mutation, mitochondria and cancer
Kamp, W. M., Wang, P., & Hwang, P. M. (2016) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2016.02.007 · Cited by 66
Yu, Z., Chen, R., Li, M., Yu, Y. Q., Liang, Y., Han, F., Qin, S., Chen, X., Su, Y., & Ge, J. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.05.054 · Cited by 61
Mechanisms and Functions of Mitophagy and Potential Roles in Renal Disease
Zuo, Z., Jing, K., Wu, H.-L., Wang, S., Ye, L., Li, Z., Yang, C., Pan, Q., Liu, W. J., & Liu, H. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00935 · Cited by 65
“Further, cytosolic p53 interacts directly with Parkin and disrupts its translocation to damaged mitochondria and subsequent clearance of damaged mitochondria by mitophagy in the mouse heart exposed to doxorubicin toxicity (Hoshino et al., 2013).”
BackgroundSIRT1 Protects the Heart from ER Stress-Induced Injury by Promoting eEF2K/eEF2-Dependent Autophagy
Pires Da Silva, J., Monceaux, K., Guilbert, A., Gressette, M., Piquereau, J., Novotova, M., Ventura-Clapier, R., Garnier, A., & Lemaire, C. (2020) · Cells · doi:10.3390/cells9020426 · Cited by 60
“Several studies have reported that mitophagy deficiency exacerbates cardiac dysfunction, leading to the proposal that mitophagy plays an essential role in adapting to myocardial stress [31,36].”
Mitophagy as a Protective Mechanism against Myocardial Stress
Nah, J., Miyamoto, S., & Sadoshima, J. (2017) · Comprehensive physiology · doi:10.1002/cphy.c170005 · Cited by 64
Mitophagy in aging and longevity
Guo, J., & Chiang, W. (2021) · IUBMB Life · doi:10.1002/iub.2585 · Cited by 62
“A major senescence regulator p53 inhibits mitophagy and promotes the accumulation of dysfunctional mitochondria.(66,67) The senescent cells exhibit a secretion pattern referred to as senescence-associated secretory phenotype (SASP).”
BackgroundThe Impact of Autophagy on Cardiovascular Senescence and Diseases
Sasaki, Y., Ikeda, Y., Iwabayashi, M., Akasaki, Y., & Ohishi, M. (2017) · International Heart Journal · doi:10.1536/ihj.17-246 · Cited by 56
Huang, D., Peng, Y., Li, Z., Chen, S., Deng, X., Shao, Z., & Ma, K. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15256 · Cited by 60
Mialet‐Perez, J., Santin, Y., & Parini, A. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1908-y · Cited by 60
Signaling Pathways Underlying Anthracycline Cardiotoxicity
Sala, V., Sala, A. D., Hirsch, E., & Ghigo, A. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8019 · Cited by 59
“In keeping with this mechanism, p53-deficient mice and Parkin-overexpressing cardiomyocytes show a less severe decline of mitochondrial integrity and cell death after treatment with Doxo (44).”
Cardiovascular disease and the biology of aging
Moturi, S., Ghosh-Choudhary, S. K., & Finkel, T. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.04.005 · Cited by 56
Wu, N., Zheng, W., Zhou, Y., Tian, Y., Tang, M., Feng, X., Ashrafizadeh, M., Wang, Y. Z., Niu, X., Tambuwala, M. M., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102428 · Cited by 63
Cucurbitacin B Protects Against Pressure Overload Induced Cardiac Hypertrophy
Xiao, Y., Yang, Z., Wu, Q., Jiang, X., Yuan, Y., Chang, W., Bian, Z., Zhu, J., & Tang, Q. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26041 · Cited by 55
“Induction of autophagy can reverse agingassociated HF and contractile dysfunction [Hoshino et al., 2013].”
BackgroundTargeting organ-specific mitochondrial dysfunction to improve biological aging
Madreiter‐Sokolowski, C. T., Hiden, U., Krstić, J., Panzitt, K., Wagner, M., Enzinger, C., Khalil, M., Abdellatif, M., Malle, E., Madl, T., et al. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108710 · Cited by 59
Forini, F., Nicolini, G., & Iervasi, G. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16036312 · Cited by 58
“In the mouse heart, p53 cytosolic accumulation induces mitochondrial dysfunction by binding to Parkin and disturbing its translocation to damaged mitochondria and their subsequent clearance by mitophagy [70].”
BackgroundDoxorubicin-induced p53 interferes with mitophagy in cardiac fibroblasts
Mancilla, T. R., Davis, L. R., & Aune, G. J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0238856 · Cited by 55
Guan, S., Xin, Y., Ding, Y., Zhang, Q., & Han, W. (2023) · Chemistry & Biodiversity · doi:10.1002/cbdv.202200730 · Cited by 58
“These findings were similar to those of previous studies that reported mitophagy providing beneficial outcomes in failing hearts.[44, 45]”
ResultCardiovascular aging: spotlight on mitochondria
Ali, M. A., Gioscia‐Ryan, R. A., Yang, D., Sutton, N. R., & Tyrrell, D. J. (2023) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00632.2023 · Cited by 59
The role of autophagic degradation in the heart
Nishida, K., Taneike, M., & Otsu, K. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.09.029 · Cited by 57
Staying young at heart: autophagy and adaptation to cardiac aging
Leon, L. J., & Gustafsson, Å. B. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.11.006 · Cited by 55
Johnson, R., Dludla, P. V., Muller, C. J. F., Huisamen, B., Essop, M. F., & Louw, J. (2017) · Molecules · doi:10.3390/molecules22020219 · Cited by 54
“STRING network analysis identified three distinct nodes within this network, including dynamin 1-like (Dnm1l), Map2k1 and cAMP-dependent protein kinase catalytic subunit (Prkacb), that are involved in the process of mitophagy [42].”
BackgroundAutophagy in cardiovascular health and disease
Abdellatif, M., Ljubojević-Holzer, S., Madeo, F., & Sedej, S. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.04.022 · Cited by 58
Wang, F., Yao, S., & Xia, H. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110601 · Cited by 55
Metadata
- Authors
- Hoshino, A., Mita, Y., Okawa, Y., Ariyoshi, M., Iwai-Kanai, E., Ueyama, T., Ikeda, K., Ogata, T., & Matoba, S.
- Affiliations
- Kyoto Prefectural University (JP)
- Corresponding author
- Matoba, Satoaki
- Venue
- Nature Communications
- Published
- 2013-08-06
- Volume
- 4
- Issue
- 1
- Pages
- 2308-2308
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2030548258
- Cited by
- 536
- References
- 54
- Citations by year
- 2026: 22 · 2025: 30 · 2024: 53 · 2023: 48 · 2022: 68 · 2021: 50 · 2020: 58 · 2019: 42 · 2018: 36 · 2017: 52 · 2016: 23 · 2015: 29 · 2014: 22 · 2013: 1
- FWCI
- 18.25
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Communications (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- Parkin, mitophagy, mitochondrial dysfunction, heart failure, cardiac aging, mitochondrial quality control, autophagy, cellular senescence, doxorubicin cardiotoxicity, cardiac dysfunction
- MeSH terms
- Aging, Animals, Cytosol, Doxorubicin, Embryo, Mammalian, Fibroblasts, Heterozygote, Humans, Mice, Transgenic, Mitochondria, Myocardium, Protein Binding, Tumor Suppressor Protein p53, Cellular Senescence, Protein Structure, Tertiary, Protein Transport, Ubiquitin-Protein Ligases, HCT116 Cells, Mice, Mitophagy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.